136 related articles for article (PubMed ID: 16822878)
1. Utility of immunohistochemical analysis for cyclo-oxygenase 2 in the differential diagnosis of osteoblastoma and osteosarcoma.
Hosono A; Yamaguchi U; Makimoto A; Endo M; Watanabe A; Shimoda T; Kaya M; Matsumura T; Sonobe H; Kusumi T; Yamaguchi T; Hasegawa T
J Clin Pathol; 2007 Apr; 60(4):410-4. PubMed ID: 16822878
[TBL] [Abstract][Full Text] [Related]
2. Role of immunohistochemical cyclo-oxygenase-2 (COX-2) and osteocalcin in differentiating between osteoblastomas and osteosarcomas.
El-Badawi ZH; Muhammad EM; Noaman HH
Malays J Pathol; 2012 Jun; 34(1):15-23. PubMed ID: 22870593
[TBL] [Abstract][Full Text] [Related]
3. β-catenin is a valuable marker for differential diagnosis of osteoblastoma and osteosarcoma.
Wan Y; Zhao W; Jiang Y; Liu D; Meng G; Cai Y
Hum Pathol; 2014 Jul; 45(7):1459-65. PubMed ID: 24746516
[TBL] [Abstract][Full Text] [Related]
4. Galectin-1 is a powerful marker to distinguish chondroblastic osteosarcoma and conventional chondrosarcoma.
Gomez-Brouchet A; Mourcin F; Gourraud PA; Bouvier C; De Pinieux G; Le Guelec S; Brousset P; Delisle MB; Schiff C
Hum Pathol; 2010 Sep; 41(9):1220-30. PubMed ID: 20399482
[TBL] [Abstract][Full Text] [Related]
5. Borderline osteoblastic tumors: problems in the differential diagnosis of aggressive osteoblastoma and low-grade osteosarcoma.
Dorfman HD; Weiss SW
Semin Diagn Pathol; 1984 Aug; 1(3):215-34. PubMed ID: 6600112
[TBL] [Abstract][Full Text] [Related]
6. Histological and immunohistochemical diversities, and proliferative activity and grading in osteosarcomas.
Hasegawa T; Hirose T; Seki K; Hizawa K; Ishii S; Wakabayashi J
Cancer Detect Prev; 1997; 21(3):280-7. PubMed ID: 9167046
[TBL] [Abstract][Full Text] [Related]
7. Osteoblastoma: a study of 12 cases.
Jambhekar NA; Desai S; Khapake D
Indian J Pathol Microbiol; 2006 Oct; 49(4):487-90. PubMed ID: 17183834
[TBL] [Abstract][Full Text] [Related]
8. Cell adhesion molecule 1 is a new osteoblastic cell adhesion molecule and a diagnostic marker for osteosarcoma.
Inoue T; Hagiyama M; Enoki E; Sakurai MA; Tan A; Wakayama T; Iseki S; Murakami Y; Fukuda K; Hamanishi C; Ito A
Life Sci; 2013 Jan; 92(1):91-9. PubMed ID: 23142238
[TBL] [Abstract][Full Text] [Related]
9. Atypical "Sclerosing" Osteoblastic Neoplasm: A Tumor of Intermediate Biological Potential Between Usual Osteoblastoma and Conventional Osteosarcoma.
McHugh KE; Reith JD; Lucas DR; Emory CL; Mesko NW; Kilpatrick SE
Am J Surg Pathol; 2019 May; 43(5):610-617. PubMed ID: 30807304
[TBL] [Abstract][Full Text] [Related]
10. The utility of SATB2 immunohistochemical expression in distinguishing between osteosarcomas and their malignant bone tumor mimickers, such as Ewing sarcomas and chondrosarcomas.
Machado I; Navarro S; Picci P; Llombart-Bosch A
Pathol Res Pract; 2016 Sep; 212(9):811-6. PubMed ID: 27465835
[TBL] [Abstract][Full Text] [Related]
11. Osteogenic tumors of bone.
Green JT; Mills AM
Semin Diagn Pathol; 2014 Jan; 31(1):21-9. PubMed ID: 24680179
[TBL] [Abstract][Full Text] [Related]
12. Osteosarcoma resembling osteoblastoma.
Bertoni F; Unni KK; McLeod RA; Dahlin DC
Cancer; 1985 Jan; 55(2):416-26. PubMed ID: 3855268
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of β-catenin expression in the differential diagnosis of osteosarcoma, osteoblastoma, and chondroblastoma.
Erdogan KE; Pacheco M; Gambarotti M; Magagnoli G; Sbaraglia M; Frisoni T; Righi A; Dei Tos AP
Virchows Arch; 2021 Sep; 479(3):529-535. PubMed ID: 33511430
[TBL] [Abstract][Full Text] [Related]
14. Comparative proteomics analysis of human osteosarcomas and benign tumor of bone.
Li Y; Liang Q; Wen YQ; Chen LL; Wang LT; Liu YL; Luo CQ; Liang HZ; Li MT; Li Z
Cancer Genet Cytogenet; 2010 Apr; 198(2):97-106. PubMed ID: 20362224
[TBL] [Abstract][Full Text] [Related]
15. Bone-Forming Tumors.
Zhang Y; Rosenberg AE
Surg Pathol Clin; 2017 Sep; 10(3):513-535. PubMed ID: 28797500
[TBL] [Abstract][Full Text] [Related]
16. Malignant transformation of aggressive osteoblastoma to ostesarcoma.
Görgün Ö; Salduz A; Kebudi R; Özger H; Bilgiç B
Eklem Hastalik Cerrahisi; 2016 Aug; 27(2):108-12. PubMed ID: 27499324
[TBL] [Abstract][Full Text] [Related]
17. KPNA2 expression is a potential marker for differential diagnosis between osteosarcomas and other malignant bone tumor mimics.
Jiang L; Liu J; Wei Q; Wang Y
Diagn Pathol; 2020 Nov; 15(1):135. PubMed ID: 33176814
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical expression of COX-2, mPGES and EP2 receptor in normal and reactive canine bone and in canine osteosarcoma.
Millanta F; Asproni P; Cancedda S; Vignoli M; Bacci B; Poli A
J Comp Pathol; 2012; 147(2-3):153-60. PubMed ID: 22633646
[TBL] [Abstract][Full Text] [Related]
19. [Morphological study of osteosarcomas in children].
Plămădeală P; Mihăilă D; Strugariu G
Rev Med Chir Soc Med Nat Iasi; 2000; 104(4):111-5. PubMed ID: 12089938
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of HLA-DR expression and T-lymphocyte infiltration in osteosarcoma.
Trieb K; Lechleitner T; Lang S; Windhager R; Kotz R; Dirnhofer S
Pathol Res Pract; 1998; 194(10):679-84. PubMed ID: 9820863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
